Dopaminergic neuroprotection and regeneration by neurturin assessed by using behavioral, biochemical and histochemical measurements in a model of progressive Parkinson's disease (Q40710921)

From Wikidata

Jump to navigation Jump to search

scientific article published on August 2002

Language	Label	Description	Also known as
English	Dopaminergic neuroprotection and regeneration by neurturin assessed by using behavioral, biochemical and histochemical measurements in a model of progressive Parkinson's disease	scientific article published on August 2002

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Dopaminergic neuroprotection and regeneration by neurturin assessed by using behavioral, biochemical and histochemical measurements in a model of progressive Parkinson's disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Parkinson's disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Yoshitsugu Oiwa

1

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Ryo Yoshimura

2

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Kunio Nakai

3

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Toru Itakura

4

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

publication date

1 August 2002

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

number of pages

13

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

947

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

271-283

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Differential effects of glial cell line-derived neurotrophic factor and neurturin on developing and adult substantia nigra dopaminergic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902934-7

7 January 2021

Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902934-7

7 January 2021

Lentiviral vectors as a gene delivery system in the mouse midbrain: cellular and behavioral improvements in a 6-OHDA model of Parkinson's disease using GDNF.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902934-7

7 January 2021

Retrograde degeneration of nigrostriatal neurons induced by intrastriatal 6-hydroxydopamine injection in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902934-7

7 January 2021

GDNF enhances the synaptic efficacy of dopaminergic neurons in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902934-7

7 January 2021

Glial cell line-derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902934-7

7 January 2021

Restorative effects of GDNF on striatal dopamine release in rats treated with neurotoxic doses of methamphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902934-7

7 January 2021

Biochemical and anatomical characterization of forepaw adjusting steps in rat models of Parkinson's disease: studies on medial forebrain bundle and striatal lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902934-7

7 January 2021

Neuroprotective mechanism of glial cell line-derived neurotrophic factor on dopamine neurons: role of antioxidation.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902934-7

7 January 2021

Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects dopaminergic terminals from degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902934-7

7 January 2021

Functional recovery in parkinsonian monkeys treated with GDNF

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902934-7

7 January 2021

GDNF improves dopamine function in the substantia nigra but not the putamen of unilateral MPTP-lesioned rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902934-7

7 January 2021

Infusion of GDNF into the cerebral spinal fluid through two different routes: effects on body weight and corticospinal neuron survival

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902934-7

7 January 2021

Expression of neurturin, GDNF, and GDNF family-receptor mRNA in the developing and mature mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902934-7

7 January 2021

Glial cell line-derived neurotrophic factor is essential for postnatal survival of midbrain dopamine neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902934-7

7 January 2021

Heparin coinfusion during convection-enhanced delivery (CED) increases the distribution of the glial-derived neurotrophic factor (GDNF) ligand family in rat striatum and enhances the pharmacological activity of neurturin

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902934-7

7 January 2021

Practical considerations for the use of the optical disector in estimating neuronal number

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902934-7

7 January 2021

Differential in vivo effects of neurturin and glial cell-line-derived neurotrophic factor.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902934-7

7 January 2021

In vivo microdialysis studies on somatodendritic dopamine release in the rat substantia nigra: effects of unilateral 6-OHDA lesions and GDNF.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902934-7

7 January 2021

Neurturin exerts potent actions on survival and function of midbrain dopaminergic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902934-7

7 January 2021

Degeneration of the nigral dopamine neurons after 6-hydroxydopamine injection into the rat striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902934-7

7 January 2021

GDNF reverses priming for dyskinesia in MPTP-treated, L-DOPA-primed common marmosets

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902934-7

7 January 2021

GDNF protection against 6-OHDA: time dependence and requirement for protein synthesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902934-7

7 January 2021

Delayed infusion of GDNF promotes recovery of motor function in the partial lesion model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902934-7

7 January 2021

Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902934-7

7 January 2021

Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902934-7

7 January 2021

Clinicopathological findings following intraventricular glial-derived neurotrophic factor treatment in a patient with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902934-7

7 January 2021

Neurturin, a relative of glial-cell-line-derived neurotrophic factor

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902934-7

7 January 2021

Delivery of a GDNF gene into the substantia nigra after a progressive 6-OHDA lesion maintains functional nigrostriatal connections

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902934-7

7 January 2021

Glial cell line derived neurotrophic factor promotes the recovery of dopamine neurons damaged by 6-hydroxydopamine in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902934-7

7 January 2021

Topographical distribution of [125I]-glial cell line-derived neurotrophic factor in unlesioned and MPTP-lesioned rhesus monkey brain following a bolus intraventricular injection

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902934-7

7 January 2021

Glial cell line-derived neurotrophic factor: distribution and pharmacology in the rat following a bolus intraventricular injection

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902934-7

7 January 2021

Analysis of the retrograde transport of glial cell line-derived neurotrophic factor (GDNF), neurturin, and persephin suggests that in vivo signaling for the GDNF family is GFRalpha coreceptor-specific.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902934-7

7 January 2021

Convection-enhanced distribution of large molecules in gray matter during interstitial drug infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902934-7

7 January 2021

GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902934-7

7 January 2021

Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson's disease in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902934-7

7 January 2021

Distribution and retrograde transport of trophic factors in the central nervous system: functional implications for the treatment of neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902934-7

7 January 2021

Protection and regeneration of nigral dopaminergic neurons by neurturin or GDNF in a partial lesion model of Parkinson's disease after administration into the striatum or the lateral ventricle

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902934-7

7 January 2021

Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902934-7

7 January 2021

Glial cell line-derived neurotrophic factor but not transforming growth factor beta 3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesion

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902934-7

7 January 2021

Neuroprotective mechanism of glial cell line-derived neurotrophic factor in mesencephalic neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902934-7

7 January 2021

Long-term protection of the rat nigrostriatal dopaminergic system by glial cell line-derived neurotrophic factor against 6-hydroxydopamine in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902934-7

7 January 2021

Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902934-7

7 January 2021

GDNF reduces drug-induced rotational behavior after medial forebrain bundle transection by a mechanism not involving striatal dopamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902934-7

7 January 2021

Neurturin protects dopaminergic neurons following medial forebrain bundle axotomy

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902934-7

7 January 2021

Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902934-7

7 January 2021

Short-term GDNF treatment provides long-term rescue of lesioned nigral dopaminergic neurons in a rat model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902934-7

7 January 2021

Identifiers

10.1016/S0006-8993(02)02934-7

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40710921&oldid=1950316128"